Which method is recommended for the safe administration of IV therapy to an infant?

Using EMLA cream for numbing during intravenous therapy is a recommended practice for infants. EMLA cream is a topical anesthetic that contains lidocaine and prilocaine, and it helps to minimize the pain or discomfort associated with needle insertion. Given that infants may not be able to fully understand or communicate their discomfort, utilizing a numbing agent is essential to facilitate a smoother experience for the child and assist healthcare providers in successfully administering IV therapy.

Performing the procedure with a numbing agent also reduces anxiety and can promote a more cooperative environment. While some of the other choices might be relevant in different contexts, they do not prioritize the pain management aspect that EMLA cream addresses directly. For example, explaining a procedure with terms that downplay pain can be helpful, but it does not replace the actual benefit of alleviating pain through a topical anesthetic. Similarly, leaving the parent out of the room or conducting the procedure in the presence of siblings may not effectively address the infant’s immediate needs for comfort and pain relief.